Evolent Health (EVH) Income towards Parent Company (2014 - 2026)

Evolent Health's Income towards Parent Company history runs 13 years deep, the most recent figure standing at -$26.6 million for Q1 2026.

• On a quarterly basis, Income towards Parent Company rose 58.8% year-over-year to -$26.6 million in Q1 2026; TTM through Mar 2026 was -$496.5 million, a 355.39% decrease from a year earlier, with the FY2025 full-year figure at -$534.5 million, changed N/A from the prior year.
• Income towards Parent Company improved to -$26.6 million in Q1 2026 per EVH's latest filing, from -$429.1 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $1.6 million in Q2 2024 and bottomed at -$429.1 million in Q4 2025.
• The 5-year median for Income towards Parent Company is -$20.9 million (2025), against an average of -$58.5 million.
• Across the five-year window, Income towards Parent Company tumbled 1781.23% in 2025 and jumped 58.8% in 2026, its largest moves.
• Year by year, Income towards Parent Company stood at -$463000.0 in 2022, then plunged by 4215.77% to -$20.0 million in 2023, then slipped by 14.15% to -$22.8 million in 2024, then tumbled by 1781.23% to -$429.1 million in 2025, then surged by 93.8% to -$26.6 million in 2026.
• Per Business Quant, the three latest EVH Income towards Parent Company figures stand at -$26.6 million (Q1 2026), -$429.1 million (Q4 2025), and -$20.9 million (Q3 2025).